Breaking News: CymaBay Seeks Rapid Approval for PBC Drug
CymaBay Therapeutics files for FDA approval of Seladelpar, hoping to offer a new solution for primary biliary cholangitis (PBC) management.
Charts and financial information provided by TradingView, a popular charting & trading platform. Check out even more advanced features or grab charts for your website.
All Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.
CymaBay Therapeutics files for FDA approval of Seladelpar, hoping to offer a new solution for primary biliary cholangitis (PBC) management.